DNA methylation profiling upon treatment with NTX-301 or decitabine in AML cells

ABSTRACT: A novel hypomethylating agent NTX-301 is a promising therapeutic agent for AML patients. To examine its mechanisms of action, we produced methylome data upon treatment with NTX-301 or decitabine (DAC) in MV4-11 cell line.

ORGANISM(S): Homo sapiens

PROVIDER: GSE187291 | GEO | 2022/11/30

REPOSITORIES: GEO